1. Home
  2. QTTB vs LIVE Comparison

QTTB vs LIVE Comparison

Compare QTTB & LIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$6.20

Market Cap

80.0M

Sector

Health Care

ML Signal

HOLD

Logo Live Ventures Incorporated

LIVE

Live Ventures Incorporated

N/A

Current Price

$13.59

Market Cap

41.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
QTTB
LIVE
Founded
2015
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
80.0M
41.2M
IPO Year
2018
1998

Fundamental Metrics

Financial Performance
Metric
QTTB
LIVE
Price
$6.20
$13.59
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$13.00
N/A
AVG Volume (30 Days)
325.4K
2.9K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
136.78
158.14
EPS
2.42
N/A
Revenue
$53,737,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.52
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.40
$7.03
52 Week High
$8.05
$25.88

Technical Indicators

Market Signals
Indicator
QTTB
LIVE
Relative Strength Index (RSI) 53.94 51.50
Support Level $5.51 $12.59
Resistance Level $6.37 $14.14
Average True Range (ATR) 0.76 0.88
MACD -0.12 0.25
Stochastic Oscillator 42.46 66.36

Price Performance

Historical Comparison
QTTB
LIVE

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).

About LIVE Live Ventures Incorporated

Live Ventures Inc is a holding company of diversified businesses. It acquires and operates companies with a history of earnings power across five segments: Retail-Entertainment, Retail-Flooring, Flooring Manufacturing, Steel Manufacturing, and Corporate & Other. Retail-Entertainment offers new and pre-owned movies, video games, music, books, comics and collectibles through an integrated buy-sell-trade model. Retail-Flooring is a retailer and installer of flooring, carpeting, and countertops, serving consumers, builders, and contractors. Flooring Manufacturing produces and distributes carpet and hard-surface flooring. Steel Manufacturing engages in steel production and fabrication, generating the majority of revenue. Corporate & Other covers corporate costs and legacy products and services.

Share on Social Networks: